OpenAlex
PricingAboutJobs
Log inGet started
Work

Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial

HTML

Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
DOI: 10.1016/s0140-6736(13)61500-7
Authors: Anthony H Barnett, Holger Huisman, Russell Jones, Maximilian von Eynatten, Sanjay Patel, Hans-Juergen Woerle
Institutions: Heart of England NHS Foundation Trust, University of Birmingham, Boehringer Ingelheim (Netherlands), Boehringer Ingelheim (United Kingdom), Boehringer Ingelheim (Germany)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: linagliptin, type 2 diabetes, elderly patients, DPP-4 inhibitors, HbA1c, glycemic control, metformin, sulfonylureas, basal insulin, hypoglycemia, adverse events, drug safety and tolerability, HbA1c reduction
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2098292453
FWCI: 17.79
Cites: 35
Cited by: 191
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security